Clinical Trial Update: Roflumilast and Cognition [Phase 2]

View source ↗

Summary

Phase 2 trial investigating roflumilast for cognitive function in dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Dementia | Phase 2 | Status: COMPLETED